23 December 2020: Clinical Research
Safety and Efficacy of Therapeutic Erythrocytapheresis Treatment in Chronic Mountain Sickness Patients in Shigatse, Tibet, China
Mingyuan Niu 1BCD* , Shekhar Singh 2EF* , Ma Mi 1B , Pian Bian 1B , Yawei Xu 2D , Zhuoga Deji 1AB* , Duoji Mima 1A* , Xiankai Li 2ACEG*DOI: 10.12659/MSM.927853
Med Sci Monit 2020; 26:e927853
Table 5 Evaluation of severity of CMS before and after TEA treatment.
| Before TEA | After TEA | P value | |
|---|---|---|---|
| 6 min walking test (m) | 550.4±79.0 | 578.5±83.1 | |
| NYHA(n) | |||
| I | 18 | 27 | |
| II | 13 | 5 | |
| III | 1 | 0 | |
| IV | 0 | 0 | |
| Borg dyspnea scale | 0.88±0.81 | 0.48±0.73 | |
| Qinghai CMS score | 7.58±2.31 | 0.45±0.85 |